EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 156 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $20,000 | -9.1% | 439 | 0.0% | 0.00% | – |
Q1 2022 | $22,000 | +633.3% | 439 | +565.2% | 0.00% | – |
Q4 2021 | $3,000 | 0.0% | 66 | +29.4% | 0.00% | – |
Q3 2021 | $3,000 | +50.0% | 51 | 0.0% | 0.00% | – |
Q2 2021 | $2,000 | 0.0% | 51 | +21.4% | 0.00% | – |
Q1 2021 | $2,000 | +100.0% | 42 | +68.0% | 0.00% | – |
Q4 2020 | $1,000 | – | 25 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Park West Asset Management LLC | 1,120,235 | $53,749,000 | 2.66% |
TANG CAPITAL MANAGEMENT LLC | 255,616 | $12,264,000 | 1.19% |
Smith, Graham & Co., Investment Advisors, LP | 158,671 | $7,613,000 | 0.92% |
ARMISTICE CAPITAL, LLC | 282,000 | $13,530,000 | 0.59% |
Capital Impact Advisors, LLC | 35,815 | $1,718,000 | 0.57% |
Matarin Capital Management, LLC | 58,977 | $2,830,000 | 0.56% |
GLOBEFLEX CAPITAL L P | 31,702 | $1,521,000 | 0.39% |
CHARTWELL INVESTMENT PARTNERS, LLC | 200,246 | $9,608,000 | 0.37% |
Stanley-Laman Group, Ltd. | 24,000 | $1,152,000 | 0.28% |
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 264 | $13,000 | 0.20% |